AR204629A1 - Procedimiento para la elaboracion de medicamentos con cesion retardada de la sustancia activa en el intestino - Google Patents

Procedimiento para la elaboracion de medicamentos con cesion retardada de la sustancia activa en el intestino

Info

Publication number
AR204629A1
AR204629A1 AR253732A AR25373274A AR204629A1 AR 204629 A1 AR204629 A1 AR 204629A1 AR 253732 A AR253732 A AR 253732A AR 25373274 A AR25373274 A AR 25373274A AR 204629 A1 AR204629 A1 AR 204629A1
Authority
AR
Argentina
Prior art keywords
intestine
medicines
procedure
preparation
active substance
Prior art date
Application number
AR253732A
Other languages
English (en)
Original Assignee
Schlueter Edelfett
Glyco Iberica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schlueter Edelfett, Glyco Iberica Sa filed Critical Schlueter Edelfett
Application granted granted Critical
Publication of AR204629A1 publication Critical patent/AR204629A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
AR253732A 1973-12-06 1974-01-01 Procedimiento para la elaboracion de medicamentos con cesion retardada de la sustancia activa en el intestino AR204629A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732360796 DE2360796B2 (de) 1973-12-06 1973-12-06 Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm

Publications (1)

Publication Number Publication Date
AR204629A1 true AR204629A1 (es) 1976-02-20

Family

ID=5900064

Family Applications (1)

Application Number Title Priority Date Filing Date
AR253732A AR204629A1 (es) 1973-12-06 1974-01-01 Procedimiento para la elaboracion de medicamentos con cesion retardada de la sustancia activa en el intestino

Country Status (11)

Country Link
US (1) US4013784A (es)
JP (1) JPS5089521A (es)
AR (1) AR204629A1 (es)
BE (1) BE811175A (es)
DE (1) DE2360796B2 (es)
DK (1) DK137310C (es)
ES (1) ES423856A1 (es)
FR (1) FR2253508B1 (es)
GB (1) GB1427677A (es)
NL (1) NL7407233A (es)
SE (1) SE7407537L (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
US5112619A (en) * 1985-11-12 1992-05-12 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulation
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
DE68906461T2 (de) * 1988-06-07 1993-10-21 Abbott Lab Feste Arzneidosis in Form eines Tablettentriturats sowie Verfahren zu deren Herstellung.
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US6177104B1 (en) 1994-01-27 2001-01-23 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving dosage form
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US6066337A (en) * 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US6187337B1 (en) 1994-01-27 2001-02-13 The Board Of Regents Of The University Of Oklahoma Rapidly dissolving dosage form
US6207199B1 (en) 1994-01-27 2001-03-27 The Board Of Regents Of The University Of Oklahoma Process for making a particulate support matrix for making a rapidly dissolving dosage form
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10300325A1 (de) * 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
US6992772B2 (en) * 2003-06-19 2006-01-31 Optix Lp Method and apparatus for optical sampling to reduce interfering variances
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
US20070082027A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
US20070082029A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
DE102013106998A1 (de) 2013-07-03 2015-01-08 Thyssenkrupp Industrial Solutions Ag Verfahren sowie eine Vorrichtung zur Herstellung einer Tablette
US10647045B1 (en) * 2016-11-03 2020-05-12 Specialty Earth Sciences, Llc Shaped or sized encapsulated reactant and method of making

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet

Also Published As

Publication number Publication date
NL7407233A (nl) 1975-06-10
SE7407537L (es) 1975-06-09
DK137310C (da) 1978-07-24
DK303974A (es) 1975-07-28
FR2253508A1 (es) 1975-07-04
BE811175A (fr) 1974-06-17
US4013784A (en) 1977-03-22
ES423856A1 (es) 1976-05-01
DE2360796A1 (de) 1975-06-12
FR2253508B1 (es) 1977-11-10
DK137310B (da) 1978-02-20
DE2360796B2 (de) 1977-06-02
GB1427677A (en) 1976-03-10
JPS5089521A (es) 1975-07-18

Similar Documents

Publication Publication Date Title
AR204629A1 (es) Procedimiento para la elaboracion de medicamentos con cesion retardada de la sustancia activa en el intestino
AR203268A1 (es) Procedimiento para la preparacion de formas farmaceuticas secas
AR195412A1 (es) Procedimiento para la preparacion de derivados de 4-difenilmetil- y 4-difenilmetilenpiperidino
AR207133A1 (es) Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano
MX4588E (es) Procedimiento para la preparacion de i-ariloxi-2-hidroxi-3-alquinilaminopropanos
AR205611A1 (es) Procedimiento para la preparacion de derivados de 3-fenoxi-2-hidroxi-propilamina
AR219038A1 (es) Procedimiento para la preparacion de derivados de 1-hidroxi-2-piridonas-6-substituidas
AR192765A1 (es) Procedimiento para la preparacion de derivados de la fenil-3-tiourea
AR197545A1 (es) Procedimiento para la preparacion de anilinobenzotiazoles
AR197093A1 (es) Procedimiento para la preparacion de compuestos de guanidina farmacologicamente activos
AR203090A1 (es) Procedimiento para la preparacion de derivados de hexahidro-pirimidino-dibenzo-azepina
AR206589A1 (es) Procedimiento para la preparacion de derivados de benzocicloheptaisoquinolina
AR207022A1 (es) Procedimiento para la preparacion de poli-n-dimetiliminoalano
AR202283A1 (es) Procedimiento para la preparacion de derivados de 1-piperidinsulfonilurea
AR206632A1 (es) Procedimiento para la preparacion de d-homoesteroides
AR205437A1 (es) Procedimiento para la preparacion de derivados de indoloquinolinona
AR201427A1 (es) Procedimiento para la preparacion de derivados de cefalosprina
AR200576A1 (es) Procedimiento para la preparacion de derivados pirazolicos
AR194081A1 (es) Procedimiento para la preparacion de derivados acilicos de la insulina
AR201072A1 (es) Procedimiento para la preparacion de ter-alquil-amino-acilo inferrior xilidida
AR206226A1 (es) Procedimiento para la elaboracion de 4-fenil-esteres de acidos 3-amino-5-sulfamoil-benzoicos
AR217238A1 (es) Procedimiento para la preparacion de derivados de 2-amino-oxazoles con utilidad farmaceutica
AR195837A1 (es) Procedimiento para la preparacion de derivados de ciclopenteno-quinolona
AR206204A1 (es) Procedimiento para la preparacion de 7-acilamido-7-alcoxicefalosporinas
AR197264A1 (es) Procedimiento para la preparacion de 3-enoleteres de delta4-ceto-19 nortestosterona